Samuel Wieand
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Public Health, StatisticsGoogle:
"Samuel Wieand"Cross-listing: PHTree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Johnston PG, Benson A, Catalano P, et al. (2005) The clinical significance of thymidylate synthase (TS) expression in primary colorectal cancer: An Intergroup combined analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3510 |
| Matin K, Jacobs SA, Richards T, et al. (2005) A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer. American Journal of Clinical Oncology. 28: 439-44 |
| Wolmark N, Wieand S, Kuebler PJ, et al. (2005) A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Survival results of NSABP Protocol C-07 Journal of Clinical Oncology. 26 |
| Matin K, Ramanathan RK, Jacobs SA, et al. (2004) Phase I/II study of trimetrexate (TMTX) and capecitabine (CAP) as second and third- line therapy in patients with advanced colorectal cancer (CRC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3673 |
| Wolmark N, Wieand S, Lembersky B, et al. (2004) A phase III trial comparing oral UFT to FULV in stage II and III carcinoma of the colon: Results of NSABP Protocol C-06 Journal of Clinical Oncology. 22: 3508-3508 |
| Roh MS, Colangelo L, Wieand S, et al. (2004) Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum Journal of Clinical Oncology. 22: 3505-3505 |
| Fisher ER, Colangelo L, Wieand S, et al. (2003) Lack of influence of cytokeratin-positive mini micrometastases in "Negative Node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01. Diseases of the Colon and Rectum. 46: 1021-5; discussion 1 |
| Jeong JH, Jung SH, Wieand S. (2003) A parametric model for long-term follow-up data from phase III breast cancer clinical trials. Statistics in Medicine. 22: 339-52 |
| Kirkwood JM, Richards T, Zarour HM, et al. (2002) Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690. Cancer. 95: 1101-12 |
| Wolmark N, Colangelo L, Wieand S. (2001) National Surgical Adjuvant Breast and Bowel Project trials in colon cancer Seminars in Oncology. 28: 9-13 |